Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

886
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
886
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.0K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodal Sequencing and Reanalysis Approaches to End the Diagnostic Odyssey of Individuals with Suspected Rare Monogenic Diseases.

Genes·2026
Same author

Extensive conjunctival papillomatosis in focal dermal hypoplasia.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus·2026
Same author

Symblepharon Release and Fornix Reconstruction after Ocular Chemical Injury: Outcomes from a Decade-Long Clinical Experience.

The British journal of ophthalmology·2026
Same author

Symptoms of Small Fiber Neuropathy in Patients With Dry Eye Disease.

Cornea·2025
Same author

Abnormal meibum is associated with SREBF1 mutation and IFAP Syndrome-2.

Experimental eye research·2025
Same author

Abnormal Meibum Is Associated With <i>SREBF1</i> Mutation And IFAP Syndrome-2.

medRxiv : the preprint server for health sciences·2025

Related Experiment Video

Updated: Dec 23, 2025

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva
07:35

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva

Published on: July 5, 2017

10.7K

Giant papillary conjunctivitis: A review.

Sarah E Kenny1, Cooper B Tye1, Daniel A Johnson1

  • 1Department of Ophthalmology, Long School of Medicine, University of Texas Health at San Antonio, San Antonio, TX, USA.

The Ocular Surface
|April 28, 2020
PubMed
Summary

Giant papillary conjunctivitis (GPC) is a common contact lens complication causing discomfort and blurred vision. Management involves contact lens cessation or medical treatment, with a good prognosis.

More Related Videos

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
05:05

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

848
Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

1.7K

Related Experiment Videos

Last Updated: Dec 23, 2025

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva
07:35

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva

Published on: July 5, 2017

10.7K
Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
05:05

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

848
Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

1.7K

Area of Science:

  • Ophthalmology
  • Contact Lens Technology
  • Immunology

Background:

  • Giant papillary conjunctivitis (GPC) is a prevalent complication among contact lens wearers.
  • Characterized by giant papillae on the superior tarsal conjunctiva, GPC causes symptoms like itching, mucus production, and reduced lens tolerance.
  • Identified risk factors include non-disposable lenses, infrequent replacement, extended wear, poor hygiene, and atopy.

Purpose of the Study:

  • To provide a comprehensive review of Giant papillary conjunctivitis (GPC) in contact lens wearers.
  • To highlight recent findings and advancements in the treatment of GPC.
  • To elucidate the pathophysiology and risk factors associated with GPC.

Main Methods:

  • Literature review of available scientific articles on GPC.
  • Analysis of the pathophysiology, risk factors, and clinical presentation of GPC.
  • Evaluation of current and emerging treatment strategies for GPC.

Main Results:

  • GPC is linked to mechanical trauma and immunologic responses to lens deposits.
  • Mild GPC cases resolve with contact lens cessation.
  • More severe cases may require antihistamines, steroids, NSAIDs, or immunomodulatory drugs.

Conclusions:

  • Giant papillary conjunctivitis (GPC) is a manageable condition with a favorable prognosis.
  • Early detection and appropriate management are crucial for successful outcomes in contact lens wearers.
  • Further research into the immunologic aspects of GPC may lead to novel therapeutic approaches.